C₂N Diagnostics
PrivateLast Round
Early Funding
Mar 13, 2025
Total Funding Raised
$32.78M
Momentum Score
25 /100
Company Overview
C2N Diagnostics is a biotechnology company that provides innovative diagnostics and therapies for Alzheimer's disease through advanced mass spectrometry techniques for the identification and monitoring of biomolecules related to neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
C₂N Diagnostics Comps
Public and private peers based on sector, stage, and business model.
C₂N Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 13, 2025 | ||||
| Grant | Jan 15, 2025 | ||||
| Grant | Sep 25, 2024 | ||||
| VC Round | Mar 6, 2024 | ||||
| Grant | Feb 16, 2023 | ||||
VC Round | May 14, 2020 |
Key People
Founding team and executive leadership
C₂N Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GHR Foundation | Grant, VC Round |
| BrightFocus Foundation | Grant |
| Samsung Venture Investment | Early Funding |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Samsung Venture Investment | Early Funding |
| Samsung Life Science Fund | Early Funding |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
Alzheimer's diagnostic tests now available in South Korea via BeauBrain Healthcare partnership.
- Mar 11, 2026
Launched Precivity Portfolio blood tests for Alzheimer's diagnosis in South Korea.
C₂N Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about C₂N Diagnostics's valuation, stock price, and market status.
